Demyelinizing Neurological Disease after Treatment with Tumor Necrosis Factor-α Antagonists

PURPOSE: Demyelinizing neurological disease is a rare complication after treatment with tumor necrosis factor (TNF)α antagonists. We report on a case of multiple sclerosis after TNFα antagonist treatment and discuss its differential diagnosis. METHODS: This is an observational case study. RESULTS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruè, Claudia, Mariotti, Cesare, Rossiello, Ilaria, Saitta, Andrea, Giovannini, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965533/
https://www.ncbi.nlm.nih.gov/pubmed/27504093
http://dx.doi.org/10.1159/000447086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965533/
https://www.ncbi.nlm.nih.gov/pubmed/27504093
http://dx.doi.org/10.1159/000447086

Ejemplares similares